BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17222240)

  • 1. Cutaneous and ocular adverse reactions in a dog following meloxicam administration.
    Niza MM; Félix N; Vilela CL; Peleteiro MC; Ferreira AJ
    Vet Dermatol; 2007 Feb; 18(1):45-9. PubMed ID: 17222240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs.
    Quaratino D; Romano A; Di Fonso M; Papa G; Perrone MR; D'Ambrosio FP; Venuti A
    Ann Allergy Asthma Immunol; 2000 Jun; 84(6):613-7. PubMed ID: 10875490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of meloxicam on severity of lameness and other clinical signs of osteoarthritis in dogs.
    Peterson KD; Keefe TJ
    J Am Vet Med Assoc; 2004 Oct; 225(7):1056-60. PubMed ID: 15515983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging diagnosis--icterus associated with a single perforating duodenal ulcer after long-term nonsteroidal antiinflammatory drug administration in a dog.
    Duerr FM; Carr AP; Bebchuk TN; Pople NC
    Can Vet J; 2004 Jun; 45(6):507-10. PubMed ID: 15283521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of vedaprofen and meloxicam in dogs with musculoskeletal pain and inflammation.
    Nell T; Bergman J; Hoeijmakers M; Van Laar P; Horspool LJ
    J Small Anim Pract; 2002 May; 43(5):208-12. PubMed ID: 12038853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs.
    Luna SP; Basílio AC; Steagall PV; Machado LP; Moutinho FQ; Takahira RK; Brandão CV
    Am J Vet Res; 2007 Mar; 68(3):258-64. PubMed ID: 17331014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Observations on the side effects after application of non-steroidal anti-inflammatory agents in dogs].
    Gassner G; Stephan I; Schütt-Mast I
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Apr; 26(2):119-23. PubMed ID: 9587983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and tolerance of meloxicam in dogs with chronic osteoarthritis.
    Doig PA; Purbrick KA; Hare JE; McKeown DB
    Can Vet J; 2000 Apr; 41(4):296-300. PubMed ID: 10769766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular toxicosis associated with the alternate administration of carprofen and meloxicam in a siberian husky.
    Nakagawa K; Yamagami T; Takemura N
    J Vet Med Sci; 2005 Oct; 67(10):1051-3. PubMed ID: 16276063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroscopic Study of Meloxicam, Tramadol, and Their Combined Administration on the Development of Gastric Injuries in Dogs.
    Eskafian H; Shojaee Tabrizi A; Ansari Lari M
    Top Companion Anim Med; 2017 Sep; 32(3):109-113. PubMed ID: 29291772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meloxicam-induced thrombocytopenia.
    Ranieri MM; Bradley EF; Simon AB
    Pharmacotherapy; 2014 Feb; 34(2):e14-7. PubMed ID: 24214337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drug-induced duodenal ulceration and perforation in a mature rottweiler.
    Reed S
    Can Vet J; 2002 Dec; 43(12):971-2. PubMed ID: 12561693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target animal safety study of meloxicam administered via transmucosal oral spray (Promist(®) technology) for 6 months in dogs.
    Hare JE; Niemuller CA; Petrick DM
    J Vet Pharmacol Ther; 2013 Aug; 36(4):412-6. PubMed ID: 23009183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meloxicam tolerance in hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Domingo MV; Marchuet MJ; Culla MT; Joanpere RS; Guadaño EM
    J Investig Allergol Clin Immunol; 2006; 16(6):364-6. PubMed ID: 17153884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal alpha1-proteinase inhibitor concentration in dogs receiving long-term nonsteroidal anti-inflammatory drug therapy.
    Murphy KF; German AJ; Ruaux CG; Steiner JM; Williams DA; Hall EJ
    Vet Clin Pathol; 2003; 32(3):136-9. PubMed ID: 12966464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopy of the gastroduodenal mucosa after carprofen, meloxicam and ketoprofen administration in dogs.
    Forsyth SF; Guilford WG; Haslett SJ; Godfrey J
    J Small Anim Pract; 1998 Sep; 39(9):421-4. PubMed ID: 9791828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
    Layton D; Hughes K; Harris S; Shakir SA
    Rheumatology (Oxford); 2003 Nov; 42(11):1332-41. PubMed ID: 12810929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-pigmenting cutaneous-mucosal fixed drug eruption due to piroxicam.
    Montoro J; Díaz M; Genís C; Lozano A; Bertomeu F
    Allergol Immunopathol (Madr); 2003; 31(1):53-5. PubMed ID: 12573211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of meloxicam on the haemostatic profile of dogs undergoing orthopaedic surgery.
    Kazakos GM; Papazoglou LG; Rallis T; Tsimopoulos G; Adamama-Moraitou K; Tea A
    Vet Rec; 2005 Oct; 157(15):444-6. PubMed ID: 16215245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.